Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeuroRPM is a digital health company focused on transforming the management of neurological conditions through remote monitoring and artificial intelligence. The company developed an FDA-cleared Apple Watch application that provides continuous, objective monitoring of Parkinson's disease symptoms, including tremors, bradykinesia, and dyskinesia. By leveraging advanced machine learning algorithms, NeuroRPM translates wearable sensor data into actionable insights for clinicians, facilitating personalized treatment plans and improved patient outcomes. The platform is designed to integrate seamlessly into a patient's daily life, offering a comprehensive view of disease progression outside of traditional clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroRPM.